Literature DB >> 22954290

Role of miRNA and cancer stem cells in chemoresistance and pancreatic cancer treatment.

Michael Danquah, Saurabh Singh, Stephen W Behrman, Ram I Mahato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22954290     DOI： 10.1517/17425247.2012.722079

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN： 1742-5247            Impact factor:   6.648


× No keyword cloud information.
  6 in total

1.  Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.

Authors:  Hardik R Mody; Sau Wai Hung; Mohammad AlSaggar; Jazmine Griffin; Rajgopal Govindarajan
Journal:  Mol Cancer Res       Date:  2016-09-13       Impact factor: 5.852

Review 2.  MicroRNAs and drug resistance in prostate cancers.

Authors:  Feng Li; Ram I Mahato
Journal:  Mol Pharm       Date:  2014-04-29       Impact factor: 4.939

3.  A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.

Authors:  Alakesh Bera; Kolaparthi VenkataSubbaRao; Muthu Saravanan Manoharan; Ping Hill; James W Freeman
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

4.  MiR-497 downregulation contributes to the malignancy of pancreatic cancer and associates with a poor prognosis.

Authors:  Jianwei Xu; Tianxiao Wang; Zhe Cao; Hua Huang; Jian Li; Wenjing Liu; Shanglong Liu; Lei You; Li Zhou; Taiping Zhang; Yupei Zhao
Journal:  Oncotarget       Date:  2014-08-30

Review 5.  The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells.

Authors:  Sabrina Bimonte; Antonio Barbieri; Maddalena Leongito; Giuseppe Palma; Vitale Del Vecchio; Michela Falco; Raffaele Palaia; Vittorio Albino; Mauro Piccirillo; Alfonso Amore; Antonella Petrillo; Vincenza Granata; Francesco Izzo
Journal:  Stem Cells Int       Date:  2016-02-24       Impact factor: 5.443

Review 6.  Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.

Authors:  Yang Shao; Hui Li; Ran Du; Jiao Meng; Gong Yang
Journal:  J Cancer       Date:  2018-04-30       Impact factor: 4.207
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.